{
  "ticker": "HAR",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02960113",
  "id": "02960113",
  "pages": 1,
  "price_sensitive": false,
  "date": "20250619",
  "time": "1433",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250619/pdf/06kx8zxx850lgk.pdf",
  "summary": "**Capital Raising Announcement**  \n- **Structure:** Placement (Tranche 2 completed) + Conversion/Creditor Shares.  \n- **Shares Issued:**  \n  - 82,780,157 Placement Shares.  \n  - 12,500,000 Conversion Shares.  \n  - 625,830 Interest Shares.  \n  - 4,539,750 Shares to settle loans/creditors.  \n- **Approval:** Shareholder approval obtained at General Meeting (11 June 2025).  \n- **Material Disclosure Exemption:** Section 708A(5)(e) notice \u2013 no Part 6D.2 disclosure.  \n- **Pending Material Info:** Pending assay results from 200 samples at Lincoln-Comet project (no further details provided).  \n- **ASX Filing:** Appendix 2A published.  \n\n**Key Points for Traders:**  \n- Dilution impact from ~100M+ new shares issued.  \n- Monitor upcoming assay results for potential catalytic news.  \n\n*(Omitted: Legal boilerplate, director/secretary names, office details.)*",
  "usage": {
    "prompt_tokens": 768,
    "completion_tokens": 225,
    "total_tokens": 993,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-19T05:30:03.872068"
}